Global stocks slide despite a historic $900 billion US stimulus package deal as threat of new virus strain in the UK casts gloom

  • Global stocks slid on Monday despite US lawmakers agreeing to a $US900 billion stimulus deal, as investors eyed the threat of a new COVID-19 mutation in the UK.
  • The federal assistance package includes $US600 in stimulus checks and $US300 in unemployment aid for every individual, both of which are half the $US1,200 amount approved by Congress and President Trump earlier this year.
  • Britain has been forced into a harsh lockdown right before the holidays, casting a gloomy outlook for the international travel industry.
  • Several countries have banned incoming flights from the UK as the new COVID-19 strain is said to be 70% more transmissible than the original virus.
  • Visit Business Insider’s homepage for more stories.

Global stocks fell on Monday despite US lawmakers striking a long-awaited deal on a historic $US900 billion stimulus package over the weekend, as concerns over a new COVID-19 strain in the UK threatens the travel industry.

Futures tied to the Dow Jones, S&P 500, and Nasdaq fell between 0.4% and 0.6%.

Meanwhile, the new sly struck US federal aid includes checks of up to $US600 for every individual and $US300 in unemployment aid per week, both of which are half the $US1,200 amount that Congress and President Donald Trump approved in March.

Votes on the new package are expected to take place Monday, only hours before the deadline for funding is due to expire at midnight — which could have led to a government shutdown.

“The package is more anti-depressant than stimulus, although sending adult Americans $US600 might lead to more spending,” said Paul Donovan, chief economist at UBS Global Wealth Management. Additional benefits of $US300 per week in the first quarter may reduce fear of unemployment, lowering precautionary savings, he said.

Despite congressional leaders clinching a deal after months of negotiations, the emergence of a contagious COVID-19 strain in the UK spooked markets as the country plunged into a harsh lockdown right before the holidays.

Read More:

BANK OF AMERICA: Buy these 26 cheap and fundamentally rock-solid stocks before the economic rebound sends them soaring in 2021

The new variant is said to be 70% more transmissible than the original virus, prompting multiple countries to ban incoming flights from the UK during an ordinarily busy Christmas season.

Britain’s FTSE 100 fell 1.2%, the Euro Stoxx 50 fell 2.3%, and Germany’s DAX fell 2.2%. The sterling fell 1.8% against the dollar to around $US1.33.

British Airways parent IAG dropped 9% in early trade, cruise operator Carnival fell 7%, while flight operator Tui and jet-engine maker Rolls-Royce also fell about 7%.

Oil prices dropped sharply on the news, with Brent Crude falling 3.6%, to $US50.37, and West Texas Intermediate falling 3.5%, to $US47.50.

The COVID-19 mutation in the UK also left Asian markets in the red, but mainland China rallied strongly — possibly on the rollout of vaccinations in the country. The Shanghai Composite rose 0.7%, while Japan’s Nikkei fell 0.2%, and Hong Kong’s Hang Seng fell 0.7%.

But a combination of the rollout of effective vaccines, US fiscal stimulus, and ongoing easy monetary policy supports further upside for equities, according to UBS.

“We recommend staying invested in equities and diversifying for the next leg of the rally,” said Mark Haefele, chief investment officer at UBS Global Wealth Management. “We see further upside in cyclical stocks such as global small caps, which tend to lead in recoveries and expansions, but which have lagged the recovery in leading economic indicators and remain attractively valued.”

Read More:

A hedge fund chief who oversees $US2 billion breaks down why we’re in for a 61% stock-market crash over the next 18-24 months — and shares 3 types of companies he’s shorting right now